Oxford Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-156,783
| Closed | -$1.78M | – | 1801 |
|
|
2019
Q3 | $1.78M | Sell |
156,783
-61,991
| -28% | -$705K | 0.04% | 612 |
|
|
2019
Q2 | $2.46M | Buy |
218,774
+22,656
| +12% | +$255K | 0.05% | 554 |
|
|
2019
Q1 | $1.59M | Buy |
196,118
+95,337
| +95% | +$771K | 0.03% | 690 |
|
|
2018
Q4 | $637K | Buy |
+100,781
| New | +$637K | 0.02% | 1087 |
|
|
2017
Q3 | – | Sell |
-134,002
| Closed | -$1.62M | – | 1559 |
|
|
2017
Q2 | $1.62M | Sell |
134,002
-59,866
| -31% | -$724K | 0.03% | 706 |
|
|
2017
Q1 | $2.49M | Buy |
+193,868
| New | +$2.49M | 0.06% | 365 |
|
|
2016
Q1 | – | Sell |
-147,812
| Closed | -$1.55M | – | 821 |
|
|
2015
Q4 | $1.55M | Sell |
147,812
-254,296
| -63% | -$2.67M | 0.04% | 443 |
|
|
2015
Q3 | $2.69M | Buy |
402,108
+209,421
| +109% | +$1.4M | 0.08% | 244 |
|
|
2015
Q2 | $1.3M | Buy |
192,687
+57,975
| +43% | +$390K | 0.04% | 415 |
|
|
2015
Q1 | $913K | Buy |
134,712
+36,632
| +37% | +$248K | 0.02% | 475 |
|
|
2014
Q4 | $722K | Buy |
+98,080
| New | +$722K | 0.02% | 520 |
|
|
2014
Q2 | – | Sell |
-98,132
| Closed | -$932K | – | 714 |
|
|
2014
Q1 | $932K | Buy |
+98,132
| New | +$932K | 0.03% | 462 |
|